News | April 11, 2024
Asahi Kasei Bioprocess and Axolabs partner to accelerate oligonucleotide therapeutics development
The partners will collaborate to build a cutting-edge oligonucleotide cGMP manufacturing facility
The partners will collaborate to build a cutting-edge oligonucleotide cGMP manufacturing facility
Wacker Biotech is a CDMO for the GMP-compliant production of active ingredients for the pharmaceutical industry
Both the Ministries signed MoU for anaemia control among adolescent girls using Ayurveda interventions
Cipla shall now have exclusive rights for the development and commercialisation of Pulmazole in all countries except the United States of America
Base4's drug discovery platform allows its collaborators to evaluate billions of novel small molecules to identify and progress RNA-modulators for important diseases
IntoCell will provide proprietary drug-linker technologies using their Ortho-Hydroxy Protected Aryl Sulfate
Dr. Reddy's will make a US$ 7.5 million upfront payment to Coya
The company has raised US$4.5 million in funding for its AI operating system
Also to be launched Scheme for promotion of Research and Innovation in Pharma MedTech Sector (PRIP)
Appointment further strengthens company’s expertise in fastest-growing therapeutic area to meet patient need
Subscribe To Our Newsletter & Stay Updated
